Service de Maladies Infectieuses - CH de Valence

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients	Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Recurrent Infection, Reinfection, bacterial infectious disease, gram-positive bacterial infections	Recruiting	Phase 1 / Phase 2	2026-09-23		NCT06306014

Clinical trials